Konrad Glund

Plus aucun poste en cours

73 ans

Health Technology

Commercial Services

Consumer Services

Profil

Konrad Glund is the founder of Vivoryon Therapeutics NV, which was founded in 1997.
He held the title of Chief Executive Officer from 2006 to 2018.
Dr. Glund is also the founder of IFB Halle GmbH.
He previously worked as Vice President-Corporate Development at Prosidion Ltd. and as a Principal at Martin-Luther-Universität Halle-Wittenberg.
Dr. Glund earned a doctorate degree from Martin-Luther-Universität Halle-Wittenberg.

Anciens postes connus de Konrad Glund

Sociétés	Poste	Fin
VIVORYON THERAPEUTICS N.V.	Directeur Général	30/04/2018
Prosidion Ltd. Prosidion Ltd. Pharmaceuticals: MajorHealth Technology Manufactures products for treatment of metabolic diseases	Corporate Officer/Principal	-
Martin-Luther-Universität Halle-Wittenberg Martin-Luther-Universität Halle-Wittenberg Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
IFB Halle GmbH	Directeur Général	-

Voir l'expérience en détail de Konrad Glund

Formation de Konrad Glund

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Konrad Glund

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	4
Prosidion Ltd. Prosidion Ltd. Pharmaceuticals: MajorHealth Technology Manufactures products for treatment of metabolic diseases	Health Technology
Vivoryon Therapeutics NV Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease	Commercial Services
Martin-Luther-Universität Halle-Wittenberg Martin-Luther-Universität Halle-Wittenberg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
IFB Halle GmbH